Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America
- PMID: 37432126
- PMCID: PMC10446870
- DOI: 10.1128/jcm.00562-23
Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America
Abstract
Dermatophytes are common causes of skin, hair, and nail infections in humans. The most common species causing infections in humans are Trichophyton rubrum, Trichophyton mentagrophytes, and Trichophyton interdigitale. Outbreaks of recalcitrant dermatophytosis have been reported in parts of South Asia, including those caused by a hypervirulent and resistant species, Trichophyton indotineae. We evaluated the antifungal susceptibility profiles of dermatophytes received by our laboratory from institutions across North America between 2021 and 2022 and performed species identification for isolates deemed to demonstrate in vitro resistance. Susceptibility testing was performed by CLSI broth microdilution methods, and species identification was performed by DNA sequence analysis. During this 2-year period, 271 dermatophyte isolates were included, the majority of which demonstrated low MIC values for terbinafine (geometric mean [GM] and modal MIC, 0.031 μg/mL and 0.008 μg/mL, respectively) and the azoles itraconazole, posaconazole, and voriconazole (0.035 to 0.049 μg/mL and ≤0.03 μg/mL). However, 18.6% of the isolates tested were resistant to terbinafine (MIC ≥ 0.5 μg/mL), including 21 T. rubrum and 21 T. indotineae isolates. These isolates were received from several different states in the United States and two provinces in Canada. In contrast, resistance to itraconazole was relatively rare. We also searched our laboratory database for earlier isolates that were resistant to terbinafine and identified 3 additional T. indotineae isolates, the earliest of which was from 2017. These results demonstrate that terbinafine resistance in dermatophytes was relatively common over this 2-year period and that T. indotineae is present in multiple areas in North America. Continued surveillance is warranted.
Keywords: Trichophyton; Trichophyton indotineae; Trichophyton rubrum; Trichophyton species; antifungal resistance; dermatophytes; terbinafine.
Conflict of interest statement
The authors declare a conflict of interest. N.P.W. has received grant support from Astellas, bioMerieux, F2G, Maxwell Biosciences, Mycovia, and Sfunga. All other authors report no conflicts.
Figures
Comment in
-
Trichophyton indotineae and other terbinafine-resistant dermatophytes in North America.J Clin Microbiol. 2023 Dec 19;61(12):e0090323. doi: 10.1128/jcm.00903-23. Epub 2023 Nov 28. J Clin Microbiol. 2023. PMID: 38014979 Free PMC article.
Similar articles
-
Detection of terbinafine-resistant Trichophyton indotineae isolates within the Trichophyton mentagrophytes species complex isolated from patients in Hue City, Vietnam: A comprehensive analysis.Med Mycol. 2024 Aug 2;62(8):myae088. doi: 10.1093/mmy/myae088. Med Mycol. 2024. PMID: 39174488
-
First Reported Cases of Terbinafine-Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment.Mycoses. 2024 Nov;67(11):e13812. doi: 10.1111/myc.13812. Mycoses. 2024. PMID: 39547945
-
Antifungal resistance in dermatophytes - review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae infections.Expert Rev Anti Infect Ther. 2024 Sep;22(9):739-751. doi: 10.1080/14787210.2024.2390629. Epub 2024 Aug 18. Expert Rev Anti Infect Ther. 2024. PMID: 39114868 Review.
-
Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1841-1846. doi: 10.1007/s10096-018-3317-4. Epub 2018 Jul 7. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29980898
-
The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?Dermatology. 2022;238(1):60-79. doi: 10.1159/000515290. Epub 2021 May 31. Dermatology. 2022. PMID: 34058736 Review.
Cited by
-
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance.Am J Clin Dermatol. 2024 May;25(3):359-389. doi: 10.1007/s40257-024-00848-1. Epub 2024 Mar 18. Am J Clin Dermatol. 2024. PMID: 38494575 Free PMC article. Review.
-
Trichophyton indotineae, an Emerging Drug-Resistant Dermatophyte: A Review of the Treatment Options.J Clin Med. 2024 Jun 18;13(12):3558. doi: 10.3390/jcm13123558. J Clin Med. 2024. PMID: 38930086 Free PMC article. Review.
-
Trichophyton concentricum fungal infections and skin microbiomes of Indigenous Peninsular Malaysians.Cell. 2025 Aug 7;188(16):4257-4274.e13. doi: 10.1016/j.cell.2025.05.034. Epub 2025 Jun 17. Cell. 2025. PMID: 40532696
-
Improving antifungal stewardship in dermatology in an era of emerging dermatophyte resistance.JAAD Int. 2024 Jan 19;15:168-169. doi: 10.1016/j.jdin.2024.01.004. eCollection 2024 Jun. JAAD Int. 2024. PMID: 38882040 Free PMC article. No abstract available.
-
Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives.J Fungi (Basel). 2023 Aug 3;9(8):820. doi: 10.3390/jof9080820. J Fungi (Basel). 2023. PMID: 37623591 Free PMC article. Review.
References
-
- de Hoog GS, Dukik K, Monod M, Packeu A, Stubbe D, Hendrickx M, Kupsch C, Stielow JB, Freeke J, Goker M, Rezaei-Matehkolaei A, Mirhendi H, Graser Y. 2017. Toward a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia 182:5–31. doi:10.1007/s11046-016-0073-9. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources